Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate

Chemistry and Biology

Volumn 7, Issue 5, 2000, Pages 313-321

  Kopytek, Stephan J ^a   Standaert, Robert F ^a   Dyer, John C D ^a   Hu, James C ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Affinity modulation; Chemically induced dimerization; Dihydrofolate reductase; Dimerizer, methotrexate

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI;

EID: 0034114574     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00109-5     Document Type: Article

References (34)

1. Amara J.F., Gilman M.et al. A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc. Natl Acad. Sci. USA. 94:1997;10618-10623.
2. Spencer D.M., Wandless T.J., Schreiber S.L., Crabtree G.R. Controlling signal transduction with synthetic ligands. Science. 262:1993;1019-1024.
3. Austin D.J., Crabtree G.R., Schreiber S.L. Proximity versus allostery: the role of regulated protein dimerization in biology. Chem. Biol. 1:1994;131-136.
4. Pruschy M.N., Spencer D.M., Kapoor T.M., Miyake H., Crabtree G.R., Schreiber S.L. Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. Chem. Biol. 1:1994;163-172.
5. Spencer D.M., Graef I., Austin D.J., Schreiber S.L., Crabtree G.R. A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc. Natl Acad. Sci. USA. 92:1995;9805-9809.
6. Holsinger L.J., Spencer D.M., Austin D.J., Schreiber S.L., Crabtree G.R. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl Acad. Sci. USA. 92:1995;9810-9814.
7. Ho S.N., Biggar S.R., Spencer D.M., Schreiber S.L., Crabtree G.R. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 382:1996;822-826.
8. Belshaw P.J., Ho S.N., Crabtree G.R., Schreiber S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl Acad. Sci. USA. 93:1996;4604-4607.
9. Rivera V.M., Gilman M.et al. A humanized system for pharmacologic control of gene expression. Nat. Med. 2:1996;1028-1032.
10. Farrar M.A., Alberol I., Perlmutter R.M. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature. 383:1996;178-181.
11. Rivera V.M. Controlling gene expression using synthetic ligands. Methods: A Companion to Methods in Enzymology. 14:1998;421-429.
12. Clackson T. Controlling mammalian gene expression with small molecules. Curr. Opin. Chem. Biol. 1:1997;210-218.
13. Pomerantz J.L., Sharp P.A., Pabo C.O. Structure-based design of transcription factors. Science. 267:1995;93-96.
14. Schmitz M.L., Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:1991;3805-3817.
15. Baccanari D., Phillips A., Smith S., Sinski D., Burchall J. Purification and properties of Escherichia coli dihydrofolate reductase. Biochemistry. 14:1975;5267-5273.
16. Ahrweiler P.M., Frieden C. Effects of point mutations in a hinge region on the stability, folding, and enzymatic activity of Escherichia coli dihydrofolate reductase. Biochemistry. 30:1991;7801-7809.
17. Jolivet J., Cowan K.H., Curt G.A., Clendeninn N.J., Chabner B.A. The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 309:1983;1094-1104.
18. Appleman J.R., Howell E.E., Kraut J., Kuhl M., Blakley R.L. Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli. J. Biol. Chem. 263:1988;9187-9198.
19. Rosowsky A., Yu C.S., Uren J., Lazarus H., Wick M. Methotrexate analogues. 13. Chemical and pharmacological studies on amide, hydrazide, and hydroxamic acid derivatives of the glutamate side chain. J. Med. Chem. 24:1981;559-567.
20. Rosowsky A., Forsch R.A., Moran R.G., Kohler W., Freisheim J.H. Methotrexate analogues. 32. Chain extension, α-carboxyl deletion, and γ-carboxyl replacement by sulfonate and phosphonate: effect on enzyme binding and cell-growth inhibition. J. Med. Chem. 31:1988;1326-1331.
21. Rosowsky A., Forsch R.A., Bader H., Freisheim J.H. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain. J. Med. Chem. 34:1991;1447-1454.
22. Rosowsky A., Forsch R.A., Freisheim J.H., Galivan J., Wick M. Methotrexate analogues. 23. Synthesis, dihydrofolate reductase affinity, cytotoxicity, and in vivo antitumor activity of some putative degradation products of methotrexate-poly(L-lysine) conjugates. J. Med. Chem. 27:1984;888-893.
23. Bolin J.T., Filman D.J., Matthews D.A., Hamlin R.C., Kraut J. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 Å resolution. I. General features and binding of methotrexate. J. Biol. Chem. 257:1982;13650-13662.
24. Matthews D.A., Hoogsteen K.et al. Dihydrofolate reductase: X-ray structure of the binary complex with methotrexate. Science. 197:1977;452-455.
25. Briesewitz R., Ray G.T., Wandless T.J., Crabtree G.R. Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces. Proc. Natl Acad. Sci. USA. 96:1999;1953-1958.
26. Rosowsky A., Beardsley G.P., Ensminger W.D., Lazarus H., Yu C.S. Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of α- and γ-monoesters as potential prodrugs. J. Med. Chem. 21:1978;380-386.
27. Sirotnak F.M., Chello P.L., Piper J.R., Montgomery J.A., Degraw J.I. Structural specificity of folate analog transport and binding to dihydrofolate reductase in murine tumor and normal cells: relevance to therapeutic efficacy. Dev. Biochem. 4:1979;597-602.
28. Piper J.R., Montgomery J.A. Amides of methotrexate. Dev. Biochem. 4:1979;261-265.
29. Rosowsky A., Forsch R., Uren J., Wick M. Methotrexate analogues. 14. Synthesis of new γ-substituted derivatives as dihydrofolate reductase inhibitors and potential anticancer agents. J. Med. Chem. 24:1981;1450-1455.
30. Mammen M., Choi S.K., Whitesides G.M. Polyvalent interactions in biological systems - implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. Engl. 37:1998;2755-2794.
31. Nagy A., Szoke B., Schally A.V. Selective coupling of methotrexate to peptide hormone carriers through a γ-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt coupling. Proc. Natl Acad. Sci. USA. 90:1993;6373-6376.
32. ®: a new peptide coupling reagent devoid of toxic by-product. Tetrahedron Lett. 31:1990;205-208.
33. 19F]tryptophan-labeled Escherichia coli dihydrofolate reductase: equilibrium folding and ligand binding studies. Biochemistry. 33:1994;5502-5509.
34. Pace C.N., Vajdos F., Fee L., Grimsley G., Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4:1995;2411-2423.